XML 124 R111.htm IDEA: XBRL DOCUMENT v3.19.1
Parent Company Only Financial Information (Interim Condensed Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Operating activities      
Net income $ 14,021 $ 13,237 $ 13,799
Adjustments to reconcile net income to cash provided by operations      
Undistributed earnings of equity securities without readily determinable fair values (144) 40 791
Share-based payment awards 612 640 573
Depreciation 2,940 2,902 2,821
Net amortization of AFS securities 1,873 2,144 2,747
Deferred Income Tax Expense (Benefit) 275 2,836 (282)
Changes in operating assets and liabilities which used cash      
Other assets 113 800 455
Accrued interest and other liabilities 358 (2,497) 550
Net cash provided by (used in) operating activities 22,010 19,721 20,240
Investing activities      
Purchases of equipment and premises (2,305) (2,038) (3,804)
Net cash provided by (used in) investing activities 6,470 (81,755) (69,909)
Financing activities      
Net increase (decrease) in other borrowed funds (4,579) 7,184 27,962
Cash dividends paid on common stock (8,169) (7,990) (7,645)
Proceeds from the issuance of common stock 6,864 6,177 5,023
Common stock repurchased (7,007) (5,181) (4,440)
Common stock purchased for deferred compensation obligations (401) (420) (383)
Net cash provided by (used in) financing activities 14,143 69,988 50,994
Increase (decrease) in cash and cash equivalents 42,623 7,954 1,325
Cash and cash equivalents at beginning of period 30,848 22,894 21,569
Cash and cash equivalents at end of period 73,471 30,848 22,894
Parent Company [Member]      
Operating activities      
Net income 14,021 13,237 13,799
Adjustments to reconcile net income to cash provided by operations      
Undistributed earnings of subsidiaries (3,769) (7,149) (8,003)
Undistributed earnings of equity securities without readily determinable fair values (144) 40 791
Share-based payment awards 612 640 573
Depreciation 134 154 156
Deferred Income Tax Expense (Benefit) (31) 792 147
Changes in operating assets and liabilities which used cash      
Other assets 1,237 42 (44)
Accrued interest and other liabilities (937) (1,590) (2,669)
Net cash provided by (used in) operating activities 11,123 6,166 4,750
Investing activities      
Maturities, calls, principal repayments, and sales of AFS securities 0 249 0
Purchases of equipment and premises (96) (113) (133)
Net cash provided by (used in) investing activities (96) 136 (133)
Financing activities      
Net increase (decrease) in other borrowed funds 0 0 0
Cash dividends paid on common stock (8,169) (7,990) (7,645)
Proceeds from the issuance of common stock 6,864 6,177 5,023
Common stock repurchased (7,007) (5,181) (4,440)
Common stock purchased for deferred compensation obligations (401) (420) (383)
Net cash provided by (used in) financing activities (8,713) (7,414) (7,445)
Increase (decrease) in cash and cash equivalents 2,314 (1,112) (2,828)
Cash and cash equivalents at beginning of period 185 1,297 4,125
Cash and cash equivalents at end of period $ 2,499 $ 185 $ 1,297